Merck KGaA scouts for more U.S. drug deals; Genmab earns $8M milestone from J&J;

@FierceBiotech: In our latest report, we feature the top women in the biotech industry. Report | Follow @FierceBiotech

@JohnCFierce: Sanofi might want to reevaluate its cancer strategy about now. Iniparib and fedratinib both written off in '13. More | Follow @JohnCFierce

@DamianFierce: Pro-23andMe petition aims to protect "potentially life-saving diagnostic kits," thereby making the FDA's case. Petition | Follow @DamianFierce

@EmilyMFierce: Harvard study: 30% of all medical tests are probably unnecessary. More | Follow @EmilyMFierce

> Germany's Merck KGaA says it is hunting up new drug deals and buyouts to help expand its U.S. drugs business. Story

> Denmark's Genmab has earned an $8 million milestone from Johnson & Johnson ($JNJ) for the advancement of their cancer drug daratumumab. Story

Medical Device News

@FierceMedDev: Becton Dickinson boost its quarterly dividend. Item | Follow @FierceMedDev

@MarkHFierce: J&J's $2.5B hip implant settlement offer is already beginning to generate some flack from patients. Story via NYT | Follow @MarkHFierce

> Hospira faces another pump recall over deadly risk. Story

> Patient anger could scuttle J&J's $2.5B hip settlement. Article

> Smith & Nephew's M&A blitz rolls on with Brazilian buy. News

> Dutch VC firm readies $200M fund with an eye on device and Dx investments. More

Pharma News

@FiercePharma: Monday's top story: Who leaked the scary Copaxone numbers? Teva intends to find out. Story | Follow @FiercePharma

@EricPFierce: Any who thinks women aren't controlling the destiny of biopharma would be wrong. Women in Biotech 2013 Report | Follow @EricPFierce

@CarlyHFierce: FDA withdraws restrictions on GSK diabetes drug Avandia - too little, too late? | Follow @CarlyHFierce

> Mylan, Biocon ready to roll out Herceptin biosimilar in India. Story

> FDA withdraws restrictions on GSK's Avandia. News

> Bayer bids $2.4B for Xofigo partner Algeta in drive for cancer growth. More

Pharma Manufacturing News

> JLL expects to buy more CMOs. Story

> Glaxo piles onto API expansion in Scotland. More

> PL Developments, Aaron combine expertise in OTC manufacturing. Article

> Ranbaxy ready to bail on vaccine manufacturing. More

> Bafna draws buyout interest for its European-approved manufacturing. News

Biotech Research News

> Eli Lilly, Project A.L.S. forge preclinical drug discovery pact. News

> Biota halts preclinical antibiotics program as antimicrobial resistance grows. Report

> New targets for Parkinson's revealed in gene network. Story

> Antibiotics may weaken body's response to cancer therapies. Article

> New York Stem Cell Foundation, NIH partner to study rare diseases. Story